Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | increases expression | EXP | | 6480464 | o and p'-DDT results in increased expression of TAF9B mRNA | CTD | PMID:24096037 | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | increases expression | ISO | Taf9b (Mus musculus) | 6480464 | o and p'-DDT results in increased expression of TAF9B mRNA | CTD | PMID:24096037 | 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of TAF9B mRNA | CTD | PMID:15212814 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TAF9B mRNA | CTD | PMID:20106945 and PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Taf9b (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of TAF9B mRNA | CTD | PMID:21570461 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of TAF9B mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of TAF9B mRNA | CTD | PMID:21346803 | 2-hydroxypropanoic acid | increases expression | ISO | TAF9B (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of TAF9B mRNA | CTD | PMID:30851411 | 3,4-dichloroaniline | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | 3 and 4-dichloroaniline results in decreased expression of TAF9B mRNA | CTD | PMID:24172598 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Taf9b (Mus musculus) | 6480464 | Fenretinide results in decreased expression of TAF9B mRNA | CTD | PMID:28973697 | 5-aza-2'-deoxycytidine | increases expression | ISO | TAF9B (Homo sapiens) | 6480464 | Decitabine results in increased expression of TAF9B mRNA | CTD | PMID:19194470 | 7,12-dimethyltetraphene | increases expression | EXP | | 6480464 | 9 more ... | CTD | PMID:19480007 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of TAF9B mRNA | CTD | PMID:31881176 | Aflatoxin B2 alpha | increases methylation | ISO | TAF9B (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of TAF9B promoter | CTD | PMID:30157460 | aflatoxin M1 | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | Aflatoxin M1 results in decreased expression of TAF9B mRNA | CTD | PMID:30928695 | all-trans-retinoic acid | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of TAF9B mRNA | CTD | PMID:21934132 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of TAF9B mRNA | CTD | PMID:16483693 | arsenite(3-) | multiple interactions | ISO | TAF9B (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to TAF9B mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | increases expression | ISO | Taf9b (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of TAF9B mRNA | CTD | PMID:22228805 | benzo[a]pyrene | increases methylation | ISO | TAF9B (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of TAF9B exon | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | TAF9B (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of TAF9B promoter | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20018196 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of TAF9B mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of TAF9B mRNA | CTD | PMID:33670352 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of TAF9B mRNA | CTD | PMID:30816183 | bisphenol A | decreases methylation | ISO | Taf9b (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of TAF9B promoter | CTD | PMID:27312807 | bromobenzene | increases expression | EXP | | 6480464 | bromobenzene results in increased expression of TAF9B mRNA | CTD | PMID:12628495 | cadmium atom | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | Cadmium results in decreased expression of TAF9B mRNA | CTD | PMID:24376830 | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of TAF9B mRNA | CTD | PMID:33453195 | caffeine | increases phosphorylation | ISO | TAF9B (Homo sapiens) | 6480464 | Caffeine results in increased phosphorylation of TAF9B protein | CTD | PMID:35688186 | carbamazepine | affects expression | ISO | TAF9B (Homo sapiens) | 6480464 | Carbamazepine affects the expression of TAF9B mRNA | CTD | PMID:24752500 | choline | multiple interactions | ISO | Taf9b (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TAF9B gene | CTD | PMID:20938992 | cobalt atom | multiple interactions | ISO | TAF9B (Homo sapiens) | 6480464 | [tungsten carbide binds to Cobalt] which results in decreased expression of TAF9B mRNA | CTD | PMID:20105288 | cobalt dichloride | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of TAF9B mRNA | CTD | PMID:20105288 | coumarin | increases phosphorylation | ISO | TAF9B (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of TAF9B protein | CTD | PMID:35688186 | crocidolite asbestos | decreases expression | ISO | Taf9b (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of TAF9B mRNA | CTD | PMID:29279043 | cyclosporin A | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of TAF9B mRNA | CTD | PMID:20106945 | DDT | increases methylation | EXP | | 6480464 | DDT results in increased methylation of TAF9B gene | CTD | PMID:30207508 | diclofenac | affects expression | ISO | TAF9B (Homo sapiens) | 6480464 | Diclofenac affects the expression of TAF9B mRNA | CTD | PMID:24752500 | dicrotophos | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of TAF9B mRNA | CTD | PMID:28302478 | diuron | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | Diuron metabolite results in decreased expression of TAF9B mRNA | CTD | PMID:24172598 | dorsomorphin | multiple interactions | ISO | TAF9B (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of TAF9B mRNA | CTD | PMID:29803840 | ethanol | affects splicing | ISO | Taf9b (Mus musculus) | 6480464 | Ethanol affects the splicing of TAF9B mRNA | CTD | PMID:30319688 | folic acid | multiple interactions | ISO | Taf9b (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TAF9B gene | CTD | PMID:20938992 | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of TAF9B gene | CTD | PMID:22079235 | gold atom | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | Gold results in decreased expression of TAF9B mRNA | CTD | PMID:25523186 | gold(0) | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | Gold results in decreased expression of TAF9B mRNA | CTD | PMID:25523186 | L-methionine | multiple interactions | ISO | Taf9b (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TAF9B gene | CTD | PMID:20938992 | manganese(II) chloride | decreases expression | EXP | | 6480464 | manganese chloride results in decreased expression of TAF9B mRNA | CTD | PMID:28801915 | methyl methanesulfonate | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of TAF9B mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of TAF9B mRNA | CTD | PMID:23179753 and PMID:28001369 | methylmercury chloride | increases expression | ISO | TAF9B (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of TAF9B mRNA | CTD | PMID:28001369 | oxybenzone | increases expression | ISO | TAF9B (Homo sapiens) | 6480464 | oxybenzone results in increased expression of TAF9B mRNA | CTD | PMID:36581016 | p-chloromercuribenzoic acid | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of TAF9B mRNA | CTD | PMID:26272509 | p-chloromercuribenzoic acid | multiple interactions | ISO | TAF9B (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TAF9B mRNA | CTD | PMID:27188386 | phenylmercury acetate | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of TAF9B mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | TAF9B (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TAF9B mRNA | CTD | PMID:27188386 | phenytoin | increases expression | EXP | | 6480464 | Phenytoin results in increased expression of TAF9B mRNA | CTD | PMID:20345932 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of TAF9B mRNA | CTD | PMID:19162173 | pirinixic acid | increases expression | ISO | Taf9b (Mus musculus) | 6480464 | pirinixic acid results in increased expression of TAF9B mRNA | CTD | PMID:20813756 | quercetin | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | Quercetin results in decreased expression of TAF9B mRNA | CTD | PMID:21632981 | rac-lactic acid | increases expression | ISO | TAF9B (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of TAF9B mRNA | CTD | PMID:30851411 | rotenone | increases expression | ISO | Taf9b (Mus musculus) | 6480464 | Rotenone results in increased expression of TAF9B mRNA | CTD | PMID:32937126 | SB 431542 | multiple interactions | ISO | TAF9B (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | decreases expression | ISO | Taf9b (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of TAF9B mRNA and sodium arsenite results in decreased expression of TAF9B protein | CTD | PMID:29044176 and PMID:37682722 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of TAF9B mRNA | CTD | PMID:19281266 | sunitinib | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of TAF9B mRNA | CTD | PMID:31533062 | thiabendazole | affects expression | EXP | | 6480464 | Thiabendazole affects the expression of TAF9B mRNA | CTD | PMID:18539377 | thimerosal | affects expression | ISO | TAF9B (Homo sapiens) | 6480464 | Thimerosal affects the expression of TAF9B mRNA | CTD | PMID:27188386 | trichloroethene | increases methylation | EXP | | 6480464 | Trichloroethylene results in increased methylation of TAF9B gene | CTD | PMID:27618143 | trichostatin A | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of TAF9B mRNA | CTD | PMID:24935251 | trichostatin A | affects expression | ISO | TAF9B (Homo sapiens) | 6480464 | trichostatin A affects the expression of TAF9B mRNA | CTD | PMID:28542535 | triptonide | increases expression | ISO | Taf9b (Mus musculus) | 6480464 | triptonide results in increased expression of TAF9B mRNA | CTD | PMID:33045310 | Tungsten carbide | multiple interactions | ISO | TAF9B (Homo sapiens) | 6480464 | [tungsten carbide binds to Cobalt] which results in decreased expression of TAF9B mRNA | CTD | PMID:20105288 | valproic acid | increases methylation | ISO | TAF9B (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of TAF9B gene | CTD | PMID:29154799 | valproic acid | affects expression | ISO | TAF9B (Homo sapiens) | 6480464 | Valproic Acid affects the expression of TAF9B mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of TAF9B mRNA | CTD | PMID:23179753 more ... | vitamin E | decreases expression | ISO | TAF9B (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of TAF9B mRNA | CTD | PMID:19244175 | vorinostat | affects expression | ISO | TAF9B (Homo sapiens) | 6480464 | vorinostat affects the expression of TAF9B mRNA | CTD | PMID:27188386 | zoledronic acid | increases expression | ISO | TAF9B (Homo sapiens) | 6480464 | zoledronic acid results in increased expression of TAF9B mRNA | CTD | PMID:20977926 | |